Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 874

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 874
---
.4Purchase Price AdjustmentA-5Section 2.5Delayed Merger ConsiderationA-6Section 2.6Exchange and PaymentA-7Section 2.7Dissenting SharesA-8Section 2.8WithholdingA-9ARTICLE IIIREPRESENTATIONS AND WARRANTIES OF THE COMPANYA-9Section 3.1Organization, Standing and PowerA-9Section 3.2Capital StockA-11Section 3.3AuthorityA-11Section 3.4No Conflict; Consents and ApprovalsA-12Section 3.5SEC Reports; Financial StatementsA-12Section 3.6No Undisclosed LiabilitiesA-14Section 3.7Absence of Certain Changes or EventsA-14Section 3.8LitigationA-14Section 3.9Compliance with LawsA-14Section 3.10Benefit PlansA-15Section 3.11Labor MattersA-16Section 3.12Employee MattersA-17Section 3.13Environmental MattersA-18Section 3.14TaxesA-19Section 3.15ContractsA-20Section 3.16InsuranceA-22Section 3.17PropertiesA-22Section 3.18Intellectual PropertyA-22Section 3.19State Takeover StatutesA-23Section 3.20No Rights PlanA-23Section 3.21Affiliate TransactionsA-23Section 3.22Foreign Corrupt Practices ActA-23Section 3.23BrokersA-24Section 3.24Export Controls and Economic SanctionsA-24Section 3.25Health Care Regulatory MattersA-24Section 3.26Data Privacy and SecurityA-26Section 3.27No Other Representations or WarrantiesA-27A-i

#### TABLE OF CONTENTS(Continued)PageARTICLE IVREPRESENTATIONS AND WARRANTIES OF PARENT AND THE MERGER SUBSA-27Section 4.1Organization, Standing and PowerA-27Section 4.2AuthorityA-28Section 4.3Capital StockA-28Section 4.4No Conflict; Consents and ApprovalsA-29Section 4.5SEC Reports; Financial StatementsA-29Section 4.6No Undisclosed LiabilitiesA-31Section 4.7BrokersA-31Section 4.8Merger SubA-31Section 4.9